当前位置： SCI文献检索 > TRANSPLANTATION期刊下所有文献 > Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients.

Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients.

Abstract：

BACKGROUND:Calcineurin inhibitor-induced renal dysfunction is a major problem in liver transplantation. Interleukin-2 receptor antagonist induction followed by delayed tacrolimus (Tac) administration may minimize the renal insult without compromising immunoprotection. METHODS:This open, randomized, multicenter trial evaluated the benefit of daclizumab induction with delayed Tac on renal function at 6 months; an observational study was continued for 18 months. Liver transplant patients with a 12-hr serum creatinine (SrC) level less than 180 micromol/L received either delayed Tac with daclizumab induction (n=98) or standard Tac (n=101) both combined with mycophenolate mofetil and steroids. The primary endpoint was the incidence of SrC level more than 130 micrommol/L at 6 months. RESULTS:The incidence was 22.4% with delayed Tac and 29.7% with standard Tac (P=ns), which remained unchanged at 12 months (21.6% and 23.9%) but increasing slightly at 24 months (29.0% and 32.9%), respectively. A post hoc analysis of renal function was done based on patients stratification by SrC at 12 hr (100 micromol/L) showing no difference in SrC values at 6 months regardless of the 12-hr values despite a trend toward better estimated glomerular filtration rate for patients with 12-hr value less than 100 micromol/L in the delayed Tac group. Biopsy-proven acute rejection was similar at 6 months (17.5% and 18.75%), 12 months (23.5% and 23.8%), and 24 months (24.5% and 25.7%), respectively. Patient and graft survival in both groups were comparable and good. Similar types and incidences of adverse events were reported in both groups at all time. CONCLUSIONS:Delay of Tac does not benefit renal function in liver transplant recipients with a good renal function at baseline.

journal_name

Transplantation

journal_title

Transplantation

authors

Calmus Y,Kamar N,Gugenheim J,Duvoux C,Ducerf C,Wolf P,Samuel D,Vanlemmens C,Neau-Cransac M,Salamé E,Chazouillères O,Declerck N,Pageaux GP,Dubel L,Rostaing L

doi

10.1097/TP.0b013e3181db8cf0

subject

Has Abstract

pub_date

2010-06-27 00:00:00

pages

1504-10

issue

eissn

0041-1337

issn

1534-6080

journal_volume

pub_type

杂志文章,多中心研究,随机对照试验

在线工具

Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients.